ASRS
ATRA icon

Arizona State Retirement System’s Atara Biotherapeutics ATRA Stock Holding History

Arizona State Retirement System’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-935
Closed -$67.8K – 2182
2023
Q1 		$67.8K Buy
935
+30
+3% +$2.91K ﹤0.01% 2159
2022
Q4 		$74.2K Buy
905
+42
+5% +$4.38K ﹤0.01% 2154
2022
Q3 		$82K Buy
863
+5
+0.6% +$562 ﹤0.01% 2104
2022
Q2 		$167K Buy
858
+45
+6% +$7.35K ﹤0.01% 1992
2022
Q1 		$189K Buy
813
+37
+5% +$11.8K ﹤0.01% 2032
2021
Q4 		$306K Sell
776
-3
-0.4% -$1.26K ﹤0.01% 1823
2021
Q3 		$348K Buy
779
+6
+0.8% +$2.15K ﹤0.01% 1744
2021
Q2 		$300K Sell
773
-87
-10% -$31K ﹤0.01% 1878
2021
Q1 		$309K Buy
860
+41
+5% +$18.1K ﹤0.01% 1805
2020
Q4 		$402K Sell
819
-2
-0.2% -$923 ﹤0.01% 1580
2020
Q3 		$266K Buy
821
+207
+34% +$70.5K ﹤0.01% 1649
2020
Q2 		$224K Buy
614
+156
+34% +$39.4K ﹤0.01% 1598
2020
Q1 		$97K Buy
+458
New +$145K ﹤0.01% 1665

Other funds holding ATRA

BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Arizona State Retirement System's ATRA Position: Q2 2023 in Review

Arizona State Retirement System sold out of Atara Biotherapeutics (ATRA) in Q2 2023, closing a stake of 935 shares — an estimated $67.8K sold.

Arizona State Retirement System first reported a position in ATRA in Q1 2020 and held it in 13 quarters. The position peaked at $402K in Q4 2020. 118 funds tracked by Wall St. Rank hold ATRA as of Q2 2023.

  • Arizona State Retirement System reported no remaining Atara Biotherapeutics position as of Q2 2023 after selling out during the quarter.
  • Arizona State Retirement System sold 935 Atara Biotherapeutics shares in Q2 2023, an estimated $67.8K.
  • Arizona State Retirement System first reported a position in Atara Biotherapeutics in Q1 2020 and held it in 13 quarters.
  • Arizona State Retirement System's Atara Biotherapeutics position peaked at $402K in Q4 2020.
  • 118 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q2 2023.

Based on Arizona State Retirement System's 13F filing for Q2 2023, filed 1 Aug 2023.